Certara (NASDAQ:CERT) Sets New 1-Year Low - Time to Sell?

Certara, Inc. (NASDAQ:CERT - Get Free Report)'s share price reached a new 52-week low on Friday . The stock traded as low as $9.25 and last traded at $9.44, with a volume of 105418 shares traded. The stock had previously closed at $9.78.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CERT. TD Cowen initiated coverage on shares of Certara in a research report on Thursday, February 27th. They issued a "buy" rating and a $16.00 price target for the company. Stephens reaffirmed an "overweight" rating and issued a $17.00 target price on shares of Certara in a research report on Thursday, February 27th. Barclays upped their price target on Certara from $12.00 to $13.00 and gave the company an "equal weight" rating in a research report on Friday, February 28th. Finally, William Blair reissued a "market perform" rating on shares of Certara in a research note on Thursday, February 27th. Four research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $15.83.

Certara Trading Up 7.5 %

The business has a 50-day moving average of $11.87 and a 200-day moving average of $11.37. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.28. The stock has a market cap of $1.57 billion, a price-to-earnings ratio of -48.65, a PEG ratio of 9.29 and a beta of 1.64.

Institutional Investors Weigh In On Certara

Several institutional investors have recently made changes to their positions in the company. Versant Capital Management Inc raised its position in Certara by 218.8% during the first quarter. Versant Capital Management Inc now owns 2,719 shares of the company's stock valued at $27,000 after acquiring an additional 1,866 shares in the last quarter. Venturi Wealth Management LLC increased its stake in shares of Certara by 839.1% during the 4th quarter. Venturi Wealth Management LLC now owns 2,808 shares of the company's stock worth $30,000 after purchasing an additional 2,509 shares during the last quarter. Wells Fargo & Company MN raised its holdings in shares of Certara by 48.4% during the 4th quarter. Wells Fargo & Company MN now owns 3,208 shares of the company's stock valued at $34,000 after purchasing an additional 1,047 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in shares of Certara in the 4th quarter valued at $47,000. Finally, Blue Trust Inc. boosted its holdings in Certara by 20.9% in the fourth quarter. Blue Trust Inc. now owns 4,747 shares of the company's stock worth $56,000 after purchasing an additional 822 shares in the last quarter. 73.96% of the stock is currently owned by institutional investors and hedge funds.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.